• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用FHV表位呈递系统对HIV-1感染患者进行V3环核心区域血清分型

V3 loop core region serotyping of HIV-1 infected patients using the FHV epitope presenting system.

作者信息

Schiappacassi M, Buratti E, D'Agaro P, Ciani L, Scodeller E S, Tisminetzky S G, Baralle F E

机构信息

International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy.

出版信息

J Virol Methods. 1997 Jan;63(1-2):121-7. doi: 10.1016/s0166-0934(96)02120-9.

DOI:10.1016/s0166-0934(96)02120-9
PMID:9015282
Abstract

We have reported recently a new epitope presenting system based on the Flock House Virus (FHV) capsid protein. The HIV-1 V3 loop core sequence IGPGRAF was inserted in different sites of this carrier molecule. Immunoreactivity experiments and molecular modelling consistently showed that the most reactive recombinant protein displayed the IGPGRAF sequence in a conformation which is most similar to that of a V3 loop reference structure. The same insertion site was then used to display the V3 loop apex sequences of six different HIV-1 isolates. Sera from 32 HIV-1 infected patients were examined for their reactivity to our chimeric proteins and the results were compared with those obtained using synthetic V3 loop peptides. The data obtained were confirmed by nested PCR amplification and direct sequencing of the patient's V3 loops. The results showed that the V3 loop serotyping using the FHV hybrid proteins, was more specific than that obtained using synthetic peptides. This system will therefore be a useful tool for the correct evaluation of the immune response against different V3 loop core sequences.

摘要

我们最近报道了一种基于鸡瘟病毒(FHV)衣壳蛋白的新型表位呈递系统。HIV-1 V3环核心序列IGPGRAF被插入到该载体分子的不同位点。免疫反应性实验和分子建模一致表明,反应性最强的重组蛋白所展示的IGPGRAF序列的构象与V3环参考结构的构象最为相似。然后使用相同的插入位点展示六种不同HIV-1分离株的V3环顶端序列。检测了32名HIV-1感染患者血清对我们嵌合蛋白的反应性,并将结果与使用合成V3环肽获得的结果进行比较。通过巢式PCR扩增和对患者V3环的直接测序证实了所获得的数据。结果表明,使用FHV杂交蛋白进行V3环血清分型比使用合成肽更具特异性。因此,该系统将成为正确评估针对不同V3环核心序列的免疫反应的有用工具。

相似文献

1
V3 loop core region serotyping of HIV-1 infected patients using the FHV epitope presenting system.使用FHV表位呈递系统对HIV-1感染患者进行V3环核心区域血清分型
J Virol Methods. 1997 Jan;63(1-2):121-7. doi: 10.1016/s0166-0934(96)02120-9.
2
Immunoreactivity of chimeric proteins carrying the HIV-1 epitope IGPGRAF. Correlation between predicted conformation and antigenicity.携带HIV-1表位IGPGRAF的嵌合蛋白的免疫反应性。预测构象与抗原性之间的相关性。
FEBS Lett. 1994 Oct 10;353(1):1-4. doi: 10.1016/0014-5793(94)00972-4.
3
Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies.能够呈现HIV-1 V3环冠部且构象适合产生447-52D样抗体的免疫原的设计。
Biochem J. 2006 Nov 1;399(3):483-91. doi: 10.1042/BJ20060588.
4
Evidence of no change in V3 loop antibody recognition pattern in HIV type 1-infected Ethiopians between 1988 and 1993.1988年至1993年间,在感染了1型艾滋病毒的埃塞俄比亚人中,V3环抗体识别模式没有变化的证据。
AIDS Res Hum Retroviruses. 1994 Nov;10(11):1551-6. doi: 10.1089/aid.1994.10.1551.
5
The V3-directed immune response in natural human immunodeficiency virus type 1 infection is predominantly directed against a variable, discontinuous epitope presented by the gp120 V3 domain.在自然感染1型人类免疫缺陷病毒过程中,针对V3的免疫反应主要针对gp120 V3结构域呈现的一个可变的、不连续的表位。
J Virol. 1997 Dec;71(12):9198-205. doi: 10.1128/JVI.71.12.9198-9205.1997.
6
Serotyping HIV type 1 by antibody binding to the V3 loop: relationship to viral genotype. WHO Network for HIV Isolation and Characterization.通过抗体与V3环结合对1型艾滋病毒进行血清分型:与病毒基因型的关系。世界卫生组织艾滋病毒分离与鉴定网络。
AIDS Res Hum Retroviruses. 1994 Nov;10(11):1379-86. doi: 10.1089/aid.1994.10.1379.
7
Presentation of native epitopes in the V1/V2 and V3 regions of human immunodeficiency virus type 1 gp120 by fusion glycoproteins containing isolated gp120 domains.通过包含分离的gp120结构域的融合糖蛋白在1型人类免疫缺陷病毒gp120的V1/V2和V3区域呈递天然表位。
J Virol. 1994 Jan;68(1):400-10. doi: 10.1128/JVI.68.1.400-410.1994.
8
Reactions of Ugandan antisera with peptides encoded by V3 loop epitopes of human immunodeficiency virus type 1.乌干达抗血清与人免疫缺陷病毒1型V3环表位编码肽的反应
AIDS Res Hum Retroviruses. 1994 May;10(5):577-83. doi: 10.1089/aid.1994.10.577.
9
Study of the V3 loop as a target epitope for antibodies involved in the neutralization of primary isolates versus T-cell-line-adapted strains of human immunodeficiency virus type 1.将V3环作为参与中和1型人类免疫缺陷病毒原代分离株与T细胞系适应株的抗体的靶表位的研究。
J Virol. 1998 Dec;72(12):9855-64. doi: 10.1128/JVI.72.12.9855-9864.1998.
10
Lack of correlation between V3-loop peptide enzyme immunoassay serologic subtyping and genetic sequencing.V3 环肽酶免疫测定血清学分型与基因测序之间缺乏相关性。
AIDS. 1998 Aug 20;12(12):1405-12. doi: 10.1097/00002030-199812000-00001.

引用本文的文献

1
Induction of HIV-blocking anti-CCR5 IgA in Peyers's patches without histopathological alterations.诱导派尔集合淋巴结中阻断 HIV 的抗 CCR5 IgA 产生而不伴有组织病理学改变。
J Virol. 2014 Apr;88(7):3623-35. doi: 10.1128/JVI.03663-13. Epub 2014 Jan 8.
2
Induction of murine mucosal CCR5-reactive antibodies as an anti-human immunodeficiency virus strategy.诱导小鼠黏膜CCR5反应性抗体作为一种抗人类免疫缺陷病毒的策略。
J Virol. 2005 Jun;79(11):6848-58. doi: 10.1128/JVI.79.11.6848-6858.2005.